XML 22 R71.htm IDEA: XBRL DOCUMENT v3.20.1
Stock-Based Compensation - Summary of Stock Options (Detail)
$ / shares in Units, $ in Thousands
3 Months Ended
Mar. 31, 2020
USD ($)
$ / shares
shares
2013 Stock Incentive Plan  
Stock Options  
Beginning balance stock options, outstanding (in shares) | shares 5,276,679
Stock options, granted (in shares) | shares 0
Stock options, exercised (in shares) | shares 0
Stock options, forfeited (in shares) | shares (674)
Stock options, expired (in shares) | shares (119,716)
Ending balance stock options, outstanding (in shares) | shares 5,156,289
Stock options, exercisable (in shares) | shares 4,141,636
Stock options, expected to vest after September 30, 2019 (in shares) | shares 1,014,653
Stock options, exercisable as of September 30, 2019 and expected to vest (in shares) | shares 5,156,289
Weighted- Average Exercise Price  
Weighted - average exercise price, outstanding (in usd per share) $ 10.57
Weighted - average exercise price, granted (in usd per share) 0
Weighted - average exercise price, exercised (in usd per share) 0
Weighted - average exercise price, forfeited (in usd per share) 11.10
Weighted - average exercise price, expired (in usd per share) 10.16
Weighted - average exercise price, outstanding (in usd per share) 10.58
Weighted - average exercise price exercisable at September 30, 2019 (in usd per share) 11.22
Weighted - average exercise price, expected to vest after September 30, 2019 (in usd per share) 7.97
Weighted - average exercise price, exercisable as of September 30, 2019 and expected to vest thereafter (in usd per share) $ 10.58
Weighted - average remaining contractual term, outstanding 6 years 6 months
Weighted - average remaining contractual term, exercisable at September 30, 2019 6 years 1 month 6 days
Weighted - average remaining contractual term, expected to vest after September 30, 2019 8 years 4 months 24 days
Weighted - average remaining contractual term, exercisable as of September 30, 2019 and expected to vest thereafter 6 years 6 months
Aggregate intrinsic value, outstanding | $ $ 0
Aggregate intrinsic value, exercisable at September 30, 2019 | $ 0
Aggregate intrinsic value, expected to vest after September 30, 2019 | $ 0
Aggregate intrinsic value, exercisable as of September 30, 2019 and expected to vest thereafter | $ $ 0
Estimated fair value of the Company's common stock (in usd per share) $ 1.93
2011 Stock Incentive Plan  
Stock Options  
Beginning balance stock options, outstanding (in shares) | shares 533,547
Stock options, granted (in shares) | shares 0
Stock options, exercised (in shares) | shares (3,597)
Stock options, forfeited (in shares) | shares (1,277)
Stock options, expired (in shares) | shares (26,694)
Ending balance stock options, outstanding (in shares) | shares 501,979
Stock options, exercisable (in shares) | shares 492,688
Stock options, expected to vest after September 30, 2019 (in shares) | shares 9,291
Stock options, exercisable as of September 30, 2019 and expected to vest (in shares) | shares 501,979
Weighted- Average Exercise Price  
Weighted - average exercise price, outstanding (in usd per share) $ 8.83
Weighted - average exercise price, granted (in usd per share) 0
Weighted - average exercise price, exercised (in usd per share) 3.68
Weighted - average exercise price, forfeited (in usd per share) 9.43
Weighted - average exercise price, expired (in usd per share) 7.74
Weighted - average exercise price, outstanding (in usd per share) 8.92
Weighted - average exercise price exercisable at September 30, 2019 (in usd per share) 8.92
Weighted - average exercise price, expected to vest after September 30, 2019 (in usd per share) 9.09
Weighted - average exercise price, exercisable as of September 30, 2019 and expected to vest thereafter (in usd per share) $ 8.92
Weighted - average remaining contractual term, outstanding 1 year 8 months 12 days
Weighted - average remaining contractual term, exercisable at September 30, 2019 1 year 8 months 12 days
Weighted - average remaining contractual term, expected to vest after September 30, 2019 3 years 6 months
Weighted - average remaining contractual term, exercisable as of September 30, 2019 and expected to vest thereafter 1 year 8 months 12 days
Aggregate intrinsic value, outstanding | $ $ 0
Aggregate intrinsic value, exercisable at September 30, 2019 | $ 0
Aggregate intrinsic value, expected to vest after September 30, 2019 | $ 0
Aggregate intrinsic value, exercisable as of September 30, 2019 and expected to vest thereafter | $ $ 0
Estimated fair value of the Company's common stock (in usd per share) $ 1.93